Haemophilus influenza type B Archives

Novavax begins early-stage trial for combined influenza/COVID-19 vaccine

Australia, COVID-19 Vaccines, Flu Vaccines, Haemophilus influenza type B, Influenza A, Novavax, Novel Coronavirus

Vaccine developer Novavax Inc. said on Sept. 8 the company initiated an early-stage study to test a combination of the flu shot NanoFlu and the Covid-19 vaccine NVX-CoV2373.

September 8, 2021/by Andrew Humphreys

Qiagen receives FDA emergency approval for coronavirus PCR test

Business, Coronavirus Tests, Emergency Use Authorization (EUA), FDA, Haemophilus influenza type B, Influenza A, Polymerase Chain Reaction (PCR), Respiratory Syncytial Virus (RSV) Infection, SARS-CoV-2 virus, Shares

Genetic testing specialist Qiagen received emergency use authorization for a new coronavirus test from the U.S. drugs regulator.

March 29, 2021/by Andrew Humphreys

Thermo Fisher Buys Mesa Biotech

Acquisitions, Business, COVID-19 Testing, Emergency Use Authorization (EUA), FDA, Haemophilus influenza type B, Infectious Diseases, Influenza A, Milestone Payments, Molecular Diagnostics, Point-Of-Care Devices, Respiratory Syncytial Virus (RSV) Infection, SARS-CoV-2 virus

Thermo Fisher Scientific is acquiring Mesa Biotech for about $450 million in cash, and will pay an additional $100 million in cash after certain milestones are hit.

January 19, 2021/by Andrew Humphreys

According to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.

December 3, 2019/by BioSpace